BA
25
4
TDC
28
2
SHW
50
-3
V
40
4
CVX
52
12
CTSH
38
-2
D
38
-3
AMG
52
5
NKE
36
2
ES
38
2
BF.B
46
-7
MET
66
6
ZION
46
-2
HCA
48
-3
AAP
20
3
EMN
46
-2
VMC
60
4
PNR
39
-2
MDT
57
-3
ABBV
64
-4
BA
25
4
TDC
28
2
SHW
50
-3
V
40
4
CVX
52
12
CTSH
38
-2
D
38
-3
AMG
52
5
NKE
36
2
ES
38
2
BF.B
46
-7
MET
66
6
ZION
46
-2
HCA
48
-3
AAP
20
3
EMN
46
-2
VMC
60
4
PNR
39
-2
MDT
57
-3
ABBV
64
-4
Financhill
Back

Brookline Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

BRKL
Brookline Bancorp

Last Price:
$10.73
Seasonality Move:
-1%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.39
Seasonality Move:
6.73%
Sell
34
Brookline Bancorp (BRKL) is a Sell

Is Brookline Bancorp a Buy, Sell or Hold?

  • The current Brookline Bancorp [BRKL] share price is $10.85. The Score for BRKL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • BRKL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRKL Stock Price Chart

What is Brookline Bancorp's stock price today?

  • The Brookline Bancorp share price today is $10.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRKL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BRKL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 29.6 Sell
Chaikin Money Flow: 324218 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.3 - 12.44) Sell
Bollinger Bands (100): (11.2 - 12.54) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

BRKL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.2 Sell
20-day SMA: 11.72 Sell
50-day SMA: 11.86 Sell
200-day SMA: 10.65 Buy
8-day EMA: 11.15 Sell
20-day EMA: 11.54 Sell
50-day EMA: 11.78 Sell
200-day EMA: 11.07 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Brookline Bancorp Earnings Growth & BRKL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.69 per share, and an increase next year of $0.02 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Brookline Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):